Microchip Technology IncStockStory recommends avoiding Microchip Technology due to 21.4% annual sales declines, 13.1% annual EPS drop, and 17.8 percentage point free cash flow margin contraction.
StockStory highlights Micron as a Nasdaq 100 stock with huge potential for long-term investors, citing 106% annual revenue growth over two years, 57.1% annual EPS gains, and a free cash flow margin expansion of 14.1 percentage points. The firm recommends avoiding Microchip Technology due to 21.4% annual sales declines, a 13.1% annual EPS drop, and a 17.8 percentage point free cash flow margin contraction. It also passes on Strategy, pointing to its core analytics software being eclipsed by a debt-financed Bitcoin strategy that amplifies downside risk, despite a vast crypto treasury offering leveraged exposure. Micron trades at 10.6 times forward P/E, while Microchip Technology and Strategy trade at 27.9 times forward P/E and 54.3 times forward price-to-sales, respectively.
Microchip Technology IncStockStory recommends avoiding Microchip Technology due to 21.4% annual sales declines, 13.1% annual EPS drop, and 17.8 percentage point free cash flow margin contraction.
Micron Technology IncStockStory highlights Micron as top Nasdaq 100 long-term buy, citing 106% annual revenue growth, 57.1% annual EPS gains, and 14.1 percentage point free cash flow margin expansion.
MicroStrategy IncorporatedStockStory passes on Strategy, citing core analytics software eclipsed by debt-financed Bitcoin strategy that amplifies downside risk.